Page last updated: 2024-10-30

leflunomide and Ischemic Attack, Transient

leflunomide has been researched along with Ischemic Attack, Transient in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Navarro, CE1
Enríquez-Ruano, P1
Enríquez-Ruano, MN1

Other Studies

1 other study available for leflunomide and Ischemic Attack, Transient

ArticleYear
Leflunomide-induced recurrent-transient ischaemic attacks in a patient with rheumatoid arthritis: first case report.
    European journal of clinical pharmacology, 2020, Volume: 76, Issue:9

    Topics: Aged, 80 and over; Arthritis, Rheumatoid; Humans; Immunosuppressive Agents; Ischemic Attack, Transie

2020
chemdatabank.com